Search results for " Replacement"

showing 10 items of 539 documents

Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study

1995

It was found that in Belgium, renal imaging techniques, demonstrating a decreased renal mass of both kidneys combined with either bumpy contours or papillary calcifications, were the only methods to reliably diagnose analgesic nephropathy (AN) in patients with end-stage renal failure. However, these criteria were selected in an area with a high prevalence of this disease (15.6% of the dialysis population at December 1990). To evaluate the criteria selected to diagnose AN in populations with lower or unknown prevalences of AN, the Analgesic Nephropathy Network of Europe (ANNE) was formed, consisting of 23 dialysis units from 14 European countries and Brazil. During 1991-1992, 598 new patient…

TransplantationKidneymedicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseAnalgesic nephropathyNephropathySurgeryDiabetic nephropathymedicine.anatomical_structureNephrologymedicineRadiologyHemodialysisRenal replacement therapyeducationbusinessDialysisNephrology Dialysis Transplantation
researchProduct

Fabry nephropathy: 5 years of enzyme replacement therapy-a short review.

2007

Fabry disease is an X-linked lysosomal storage disease, resulting from a deficiency of the enzyme α-galactosidase A and subsequent cellular storage of the enzyme substrate globotriaosylceramide (Gb3) [1]. Estimates of the incidence of Fabry disease vary markedly, from 1:<5000 male births in a newborn screening study in Italy [2] to 1:117 000 male births in Australia [3] and 1:833 000 male births in northern Portugal [4]. In general, hemizygous males are more severely affected than heterozygous females. In males, life expectancy is reduced by an average of 20 years [5] and in females by 15 years [6]. Although males tend to suffer symptoms earlier than females, both boys and girls can be affe…

TransplantationPediatricsmedicine.medical_specialtyNewborn screeningFabry diseasekidneyACE inhibitorsbusiness.industryGlobotriaosylceramideEnzyme replacement therapymedicine.diseaseFabry diseaseNephropathyTransplantationangiotensin receptor blockerschemistry.chemical_compoundchemistryNephrologymedicineLysosomal storage diseasenephropathyIn-Depth Clinical ReviewbusinessCause of deathenzyme replacement therapyNDT plus
researchProduct

Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition

2021

Despite the abundant literature on vasopressor therapy, few studies have focused on vasopressor-sparing strategies in patients with shock. We performed a scoping-review of the published studies evaluating vasopressor-sparing strategies by analyzing the results from randomized controlled trials conducted in patients with shock, with a focus on vasopressor doses and/or duration reduction. We analyzed 143 studies, mainly performed in septic shock. Our analysis demonstrated that several pharmacological and non-pharmacological strategies are associated with a decrease in the duration of vasopressor therapy. These strategies are as follows: implementing a weaning strategy, vasopressin use, system…

Vasopressinmedicine.medical_specialtyendocrine systemEvidence-based practicemedicine.medical_treatmentReviewvasopressorshocklaw.inventionnorepinephrineNorepinephrine (medication)Sepsissepsis03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineRenal replacement therapyIntensive care medicinebusiness.industrySeptic shockweaningR030208 emergency & critical care medicineGeneral Medicinemedicine.disease030228 respiratory systemShock (circulatory)Medicinemedicine.symptombusinesshormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Clinical Medicine
researchProduct

Treatment of Anderson-Fabry Disease

2020

Fabry disease is an X-linked disorder of glycosphingolipid metabolism that results in progressive accumulation of neutral glycosphingolipids, predominantly globotriaosylsphingosine (Gb3) in lysosomes, as well as other cellular compartments of several tissues, causing multi-organ manifestations (acroparesthesias, hypohidrosis, angiokeratomas, signs and symptoms of cardiac, renal, cerebrovascular involvement). Pathogenic mutations lead to a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA). In the presence of high clinical suspicion, a careful physical examination and specific laboratory tests are required. Finally, the diagnosis of Fabry’s disease is confirmed by the demonstrat…

Viral vectorsMaleGenetic enhancementChaperone therapyPhysical examinationDiseaseKidneyViral vector03 medical and health sciencesGene therapy0302 clinical medicineDrug DiscoverymedicineHumansEnzyme Replacement Therapy030304 developmental biologyPharmacology0303 health sciencesmedicine.diagnostic_testbusiness.industryPharmacologicalGenetic TherapyEnzyme replacement therapymedicine.diseaseFabry diseasePharmacological chaperonealpha-GalactosidaseImmunologyFabry DiseaseFemaleStem cellbusiness030217 neurology & neurosurgerymedicine.drugCurrent Pharmaceutical Design
researchProduct

Evaluation of the long-term treatment effects of idursulfase using statistical modelling: Data from the Hunter Outcome Survey (HOS)

2019

Treatment for mucopolysaccharidosis type II (MPS II Hunter syndrome) is available in the form of intravenous enzyme replacement therapy (ERT) with idursulfase (Shire, Lexington, MA, USA). This analysis used statistical modelling to evaluate the long-term treatment effects of idursulfase on selected clinical parameters based on data from HOS, a global, observational registry (Shire, Lexington, MA, USA). Mixed modelling was used to analyse data from male patients followed prospectively in HOS who had received idursulfase for 5-8 years and information available for two or more timepoints, of which one was pre-ERT. Data were excluded from patients with only pre-ERT information available, who ha…

Vital capacitymedicine.medical_specialtyIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismHunter syndromeEnzyme replacement therapymedicine.diseaseBiochemistryClinical trialFEV1/FVC ratioEndocrinologyInternal medicineGeneticsmedicineObservational studyMucopolysaccharidosis type IIbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

The Challenges in Moving from Ageing to Successful Longevity

2014

During the last decades survival has significantly improved and centenarians are becoming a fast-growing group of the population. Human life span is mainly dependent on environmental and genetic factors. Favourable modifications of lifestyle factors (e.g. physical activity, diet and not smoking) and healthcare (e.g. effective vascular disease prevention) have also increased human life span. Genetic factors contribute to the variation of human life span by around 25%, which is believed to be more profound after 85 years of age. It is likely that multiple factors influence life span and we need answers to questions such as: 1) What does it take to reach 100?, 2) Do centenarians have better he…

ageing longevity age-related diseasesGerontologyAgingYounger ageHormone Replacement Therapymedia_common.quotation_subjectLongevityPopulationHealth careAnimalsHumansMedicineeducationLife Stylemedia_commonSettore MED/04 - Patologia GeneraleAged 80 and overPharmacologyeducation.field_of_studyAnimalbusiness.industryLongevityCognitionDietNutrigenomicsAgeingLife expectancyCardiology and Cardiovascular MedicinebusinessHumanCurrent Vascular Pharmacology
researchProduct

Enteromyxum leei (Myxozoa: Myxosporea) infection in gilthead sea bream (Sparus aurata): Immune-related studies

2013

La presente tesis doctoral estudia diversos aspectos de la enteromixosis de la dorada, relacionados principalmente con la transmisión y la caracterización del parásito, con los factores que afectan a su establecimiento en el hospedador y a la interacción parásito-hospedador, y con la respuesta inmunitaria inducida por el parásito. En primer lugar, se desarrolló un nuevo método de transmisión de E. leei, que mejora los resultados obtenidos por los hasta ahora disponibles. El parásito se transmitió con éxito a doradas mediante intubación por vía anal de raspados intestinales de peces infectados. Con este método, se consiguió una infección más rápida y extensa que por efluente y por cohabitaci…

aquacultureSparus aurata:CIENCIAS AGRARIAS::Peces y fauna silvestre ::Piscicultura [UNESCO]enteromyxosisparasiteUNESCO::CIENCIAS AGRARIAS::Ciencias veterinariasMyxozoa:CIENCIAS AGRARIAS::Ciencias veterinarias [UNESCO]UNESCO::CIENCIAS AGRARIAS::Peces y fauna silvestre ::Pisciculturavegetable replacement dietimmune response
researchProduct

Cardiovascular Disease and SERMs

2006

business.industryMedicineDiseaseHormone replacement therapybusinessBioinformatics
researchProduct

Financial Aspects of Cervical Disc Arthroplasty: A Narrative Review of Recent Literature

2020

Recently, there has been significant interest in understanding the cost-effectiveness of treatments in spine surgery as health care systems in the United States move toward value-based care and alternative payment models. Previous studies have shown comparable outcomes of cervical disc arthroplasty (CDA) and anterior cervical discectomy fusion; however, there is a lack of consensus on the cost-effectiveness of CDA to support full adoption. Evidence of the limitations of these cost-analysis studies also exists in the literature, including industry funding, potential selection bias, and varying methods of calculating value. The goal of this narrative review is to provide an overview of the co…

cervical disc arthroplastyTotal Disc Replacementmedicine.medical_specialtyCost effectivenessCost-Benefit Analysismedia_common.quotation_subjectmedicine.medical_treatmentAnterior cervical discectomy and fusionIntervertebral Disc Degeneration03 medical and health sciences0302 clinical medicineSpine surgeryHealth careHumansMedicinePatient Reported Outcome MeasuresRadiculopathyIntensive care medicinecost-effectivenesshealth care economics and organizationsmedia_commonSelection biasbusiness.industryArthroplastyUnited StatesSpinal Fusioncost-analysis studie030220 oncology & carcinogenesisCervical VertebraeCosts and Cost AnalysisSurgeryNarrative reviewQuality-Adjusted Life YearsNeurology (clinical)businessCervical discSpinal Cord Compression030217 neurology & neurosurgeryanterior cervical discectomy and fusionDiskectomy
researchProduct

Safety and efficacy of cervical disc arthroplasty in preventing the adjacent segment disease: a meta-analysis of mid- to long-term outcomes in prospe…

2019

Objectives: Cervical disc arthroplasty (CDA) has become an alternative treatment for cervical radiculopathy and myelopathy. This technique preserves appropriate motion at both the index and adjacent disc levels and consequently may prevent adjacent segment degeneration (ASD). The authors performed a meta-analysis to compare the safety and efficacy of CDA to those of the gold standard, anterior cervical discectomy and fusion (ACDF). Both surgical and clinical parameters were employed to verify the hypothesis that CDA can reduce the risk of ASD. Methods: The meta-analysis comprised high-quality randomized controlled trials that compared CDA and ACDF treatments of cervical degenerative disc di…

cervical disc arthroplastymedicine.medical_specialtyVisual analogue scalemedicine.medical_treatmentAnterior cervical discectomy and fusionReview030204 cardiovascular system & hematologylaw.inventionDegenerative disc disease03 medical and health sciencesMyelopathy0302 clinical medicineRandomized controlled triallawmedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsCDDDACDFNeck painChemical Health and Safetybusiness.industrycervical degenerative disc diseaseGeneral Medicinemedicine.diseaseArthroplastySurgerymeta-analysisCDAMeta-analysisrandomized controlled trialcervical total disc replacementCTDRmedicine.symptombusinessSafety Researchanterior cervical discectomy and fusionRCTTherapeutics and Clinical Risk Management
researchProduct